| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |